Copyright
©The Author(s) 2021.
World J Gastroenterol. Aug 21, 2021; 27(31): 5201-5218
Published online Aug 21, 2021. doi: 10.3748/wjg.v27.i31.5201
Published online Aug 21, 2021. doi: 10.3748/wjg.v27.i31.5201
Table 1 Features of various diagnostic studies in systemic sclerosis diagnosis
| Diagnostic study | Role in SSc |
| Esophagogastroduodenoscopy | Evaluates for esophageal causes of dysphagia[4] |
| Shows reflux-related complications: erosive esophagitis, strictures, Barrett’s esophagus, esophageal adenocarcinoma[4] | |
| Reveals esophageal findings in asymptomatic patients[4] | |
| Esophageal manometry | Detects esophageal dysmotility, even in early stages of SSc[4] |
| Shows decreased lower esophageal sphincter pressure and absent peristalsis in distal two-thirds of esophagus[4] | |
| Pharyngeal manometry | Evaluates for oropharyngeal dysphagia by assessing upper esophageal sphincter relaxation and pharyngeal propulsion[38] |
| Esophageal pH monitoring (with or without impedance) | Gold standard for gastroesophageal reflux detection[4] |
| Used for patients with resistant reflux[4] | |
| Videofluorography swallow study of esophagus | Shows esophageal dysmotility with decreased peristalsis in distal 2/3 of esophagus[13] |
| Shows decrease of lower esophageal sphincter pressure[13] | |
| Shows dilated lumen of esophagus[13] | |
| CT chest | Shows esophageal dilation[13] |
Table 2 Scoring system of gastrointestinal symptoms based on UCLA Scleroderma Clinical Trial Consortium GIT 2.0[14]
| Scales | None-to-mild symptoms | Moderate symptoms | Severe-to-very severe symptoms |
| Reflux | |||
| Distension/bloating | |||
| Diarrhea | |||
| Constipation | |||
| Fecal soilage | |||
| Emotional well being | |||
| Social functioning | |||
| Total GIT score |
Table 3 Treatment options for the various disease processes that contribute to the development of dysphagia in systemic sclerosis
| Disease process | Therapeutic plan |
| Xerostomia | Drinking water more frequently[2] |
| Using artificial saliva as needed[2] | |
| Using special toothpastes and mouthwashes[2] | |
| Avoiding medications that exacerbate dry mouth[2] | |
| Microstomia | Performing exercises and massages to stretch the mouth[2] |
| Dental decay | Planning regular follow-up with experienced dentist[2] |
| Concurrent myositis | Frequent screening for myositis in patients with SSc and suggestive symptoms[37] |
| Treating concurrent myositis with immunomodulatory therapy and interventional procedures[37] | |
| Esophageal Dysmotility | Lifestyle management (taking smaller bites, chewing food thoroughly, drinking adequate water with food)[16] |
| GERD | Medications (PPIs, H2RAs)[2,52] |
| Dietary modifications (avoiding acidic foods)[52] | |
| Lifestyle modifications (avoiding meals before bedtime, elevating the head of the bed while sleeping)[2,57] | |
| Candida esophagitis | Screening for fungal esophagitis in patients with SSc and suggestive symptoms[73] |
| Prompt antifungal treatment[73] | |
| Pill esophagitis | Avoiding medications at high risk of causing esophagitis[79] |
| Screening for esophagitis in SSc patients taking culprit medications with suggestive symptoms[79] | |
| Gastroparesis | Medications (prokinetic agents)[2] |
| Dietary modifications of small frequent meals with fiber[2] |
- Citation: Kadakuntla A, Juneja A, Sattler S, Agarwal A, Panse D, Zakhary N, Pasumarthi A, Shapiro L, Tadros M. Dysphagia, reflux and related sequelae due to altered physiology in scleroderma. World J Gastroenterol 2021; 27(31): 5201-5218
- URL: https://www.wjgnet.com/1007-9327/full/v27/i31/5201.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i31.5201
